US Oncology Image About Us | Careers | Contact Us | News Room

Home > News Room > News Releases
News Releases
Article << February >> << 2010 >>
US Oncology Reports 2009 Fourth Quarter and Year End Operating Results

10 PERCENT INCREASE IN ADJUSTED EBITDA TO $241 MILLION FOR FISCAL 2009
   
THE WOODLANDS, TX, February 25, 2010 – US Oncology, Inc. (“US Oncology” or “the Company”), reported revenue growth in the fourth quarter of 2009 of 5.1 percent to $886.0 million from $842.7 million in the same period in 2008. Adjusted EBITDA increased by 10.7 percent in the fourth quarter of 2009 to $61.1 million from $55.2 million in the same period in 2008 (see definition of Adjusted EBITDA in “Discussion of Non-GAAP Information” in this release). Read release.


Bookmark and Share
US Oncology announces expanded educational resources to cancer patients through new affiliations with CURE & NexCura
February 24, 2010 Read More >
CURE Magazine Joins US Oncology
February 17, 2010 Read More >
What to Look for When Selecting an Electronic Health Record for your Community Oncology Practice - Free Educational Webinar
February 12, 2010 Read More >
Bookmark and Share
Print E-Mail Text Size Smaller text size Larger text size
Blogs
LegisLink
CURE Subscription
US ONCOLOGY VIDEO
  • US Oncology Research : US Oncology Research is now one of the largest community-based research programs in the U.S. Over the years more than 50,000 patients have participated in over 1,200 clinical trials in our program.
  • Advancing the Science of Care : Investigators in The US Oncology Network advance the science of cancer treatment to enhance patient care.
  • Expanding Patient Access to Quality Care : McKesson Specialty Health and The US Oncology Network will align resources to make sure that patients receive the best care.
  • Proving Outcomes with Health Information Technology : Health Information Systems make it possible to prove outcomes in a large patient population
  • Changing Patient Care through the US Oncology Research Network : Dr. Daniel Von Hoff highlights the commitment of the US Oncology Research Network investigators
  • US Oncology Commitment to Level I Pathways Development : Keeping Level I Pathways current with the latest scientific literature and robust physician evaluation
View Larger >
Global Navigation
About Us
Careers
Contact Us
News
Blog
 
Choose Your Path
Patients
Oncologists
Referring Physicians
Cancer Care Advocates
Section Pages
News Releases Archive
Legal and Policy
Terms of Use
For Employees
Sitemap
Technical Help
Follow Us:
Twitter YouTube
© 2014 McKesson Specialty Health. All rights reserved.